Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Etamsylate (Dicynone) for Menorrhagia
2009-013485-23Phase 3Completed
- Sponsor
- OM Pharma
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypermenorrhea comparing Etamsylate (Dicynone) with Placebo (2 arms). Primary endpoint: Menstrual blood loss during the 3rd treatment cycle. Started Dec 2009; status: completed.
02
Drugs
etamsylate
03
Conditions
hypermenorrhea
Beyond the preview
Go deeper on 2009-013485-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013485-23.